Donor KIR haplotype B improves progression-free and overall survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma

被引：27
|
作者：
Kroeger, N. [1 ]
Zabelina, T. [1 ]
Berger, J. [2 ]
Duske, H. [3 ]
Klyuchnikov, E. [1 ]
Binder, T. [3 ]
Stuebig, T. [1 ]
Hilde-Brandt, Y. [1 ]
Atanackovic, D. [4 ]
Alchalby, H. [1 ]
Ayuk, F. [1 ]
Zander, A. R. [1 ]
Bacher, U. [1 ]
Eiermann, T. [3 ]
机构：
[1] Univ Hosp Hamburg Eppendorf, Clin Stem Cell Transplantat, Hamburg, Germany
[2] Univ Hosp Hamburg Eppendorf, Univ Med Ctr, Inst Stat, Hamburg, Germany
[3] Univ Hosp Hamburg Eppendorf, Univ Med Ctr, Inst Transfus Med, Hamburg, Germany
[4] Univ Hosp Hamburg Eppendorf, Univ Med Ctr, Dept Hematol Oncol, Hamburg, Germany
来源：
LEUKEMIA | 2011年 / 25卷 / 10期
关键词：
LIGAND MISMATCH; RELAPSE; LEUKEMIA; IMPACT; GENES;
D O I：
10.1038/leu.2011.138
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1657 / 1661
页数：6
相关论文
共 50 条
  • [21] Geriatric syndromes in 2-year, progression-free survivors among older recipients of allogeneic hematopoietic cell transplantation
    Lin, Richard J.
    Baser, Raymond E.
    Elko, Theresa A.
    Korc-Grodzicki, Beatriz
    Shahrokni, Armin
    Maloy, Molly A.
    Young, James W.
    Tamari, Roni
    Shah, Gunjan L.
    Shaffer, Brian C.
    Scordo, Michael
    Sauter, Craig S.
    Ponce, Doris M.
    Politikos, Ioannis
    Perales, Miguel-Angel
    Papadopoulos, Esperanza B.
    Gyurkocza, Boglarka
    Dahi, Parastoo B.
    Cho, Christina
    Barker, Juliet N.
    Tomas, Ana Alarcon
    Flores, Nerea Castillo
    Sanchez-Escamilla, Miriam
    Segundo, Lucrecia Yanez San
    Jakubowski, Ann A.
    Giralt, Sergio A.
    BONE MARROW TRANSPLANTATION, 2021, 56 (01) : 289 - 292
  • [22] Outcome of donor lymphocyte infusion after allogeneic hematopoietic stem cell transplantation in relapsed myelodysplastic syndrome
    Marumo, Atsushi
    Nagata, Yasunobu
    Fujioka, Machiko
    Kurosawa, Shuhei
    Najima, Yuho
    Sakaida, Emiko
    Doki, Noriko
    Fukushima, Kentaro
    Ota, Shuichi
    Shono, Katsuhiro
    Ito, Ayumu
    Uchida, Naoyuki
    Nishida, Tetsuya
    Sawa, Masashi
    Tsunemine, Hiroko
    Matsuoka, Ken-ichi
    Fukuda, Takahiro
    Makoto, Onizuka
    Kanda, Yoshinobu
    Itonaga, Hidehiro
    CYTOTHERAPY, 2025, 27 (02) : 222 - 228
  • [23] Secondary monoclonal gammopathy of undetermined significance after allogeneic stem cell transplantation in multiple myeloma
    Schmitz, Marian F.
    Otten, Henny G.
    Franssen, Laurens E.
    van Dorp, Suzanne
    Strooisma, Theo
    Lokhorst, Henk M.
    van de Donk, Niels W. C. J.
    HAEMATOLOGICA, 2014, 99 (12) : 1846 - 1853
  • [24] Efficacy of donor lymphocyte infusion in patients after different types of allogeneic hematopoietic stem cell transplantation
    Slesarchuk, O. A.
    Babenko, E. V.
    Semenova, E. V.
    Bondarenko, S. N.
    Estrina, M. A.
    Morozova, E. V.
    Paina, O. V.
    Vavilov, V. N.
    Smirnov, B. I.
    Zubarovskaya, L. S.
    Afanasyev, B. V.
    TERAPEVTICHESKII ARKHIV, 2013, 85 (07) : 26 - 33
  • [25] In vivo T-Cell Depletion with Antithymocyte Globulins Improves Overall Survival after Myeloablative Allogeneic Stem Cell Transplantation in Patients with Hematologic Disorders
    Sheng, Zhixin
    Ma, Huanwen
    Pang, Wenzheng
    Niu, Shaona
    Xu, Jingbo
    ACTA HAEMATOLOGICA, 2013, 129 (03) : 146 - 153
  • [26] Effect of Donor KIR2DL1 Allelic Polymorphism on the Outcome of Pediatric Allogeneic Hematopoietic Stem-Cell Transplantation
    Bari, Rafijul
    Rujkijyanont, Piya
    Sullivan, Erin
    Kang, Guolian
    Turner, Victoria
    Gan, Kwan
    Leung, Wing
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (30) : 3782 - +
  • [27] Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation
    Venstrom, Jeffrey M.
    Gooley, Ted A.
    Spellman, Stephen
    Pring, James
    Malkki, Mari
    Dupont, Bo
    Petersdorf, Effie
    Hsu, Katharine C.
    BLOOD, 2010, 115 (15) : 3162 - 3165
  • [28] Partial T-cell depletion improves the composite endpoint graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic stem cell transplantation
    Simonetta, Federico
    Masouridi-Levrat, Stavroula
    Beauverd, Yan
    Tsopra, Olga
    Tirefort, Yordanka
    Koutsi, Aikaterini
    Stephan, Caroline
    Polchlopek-Blasiak, Karolina
    Pradier, Amandine
    Dantin, Carole
    Ansari, Marc
    Roosnek, Eddy
    Chalandon, Yves
    LEUKEMIA & LYMPHOMA, 2018, 59 (03) : 590 - 600
  • [29] Risk factors and survival outcomes in children with early cardiotoxicity after allogeneic hematopoietic stem cell transplantation
    Tong, Ke
    Meng, Yan
    Zhang, Luying
    Lei, Xiaoying
    Liu, Qihui
    Guan, Xianmin
    Yu, Jie
    Dou, Ying
    ANNALS OF HEMATOLOGY, 2024, 103 (07) : 2485 - 2497
  • [30] Short progression-free survival predicts for poor overall survival in older patients with multiple myeloma treated upfront with novel agent-based therapy
    Migkou, Magdalini
    Kastritis, Efstathios
    Roussou, Maria
    Gkotzamanidou, Maria
    Gavriatopoulou, Maria
    Nikitas, Nikitas
    Mparmparoussi, Despina
    Matsouka, Charis
    Gika, Dimitra
    Terpos, Evangelos
    Dimopoulos, Meletios A.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2011, 87 (04) : 323 - 329
12345